Health Care [ 6/12 ] | Biotechnology [ 45/74 ]
NASDAQ | Common Stock
PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs.
Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions.
It is also developing OncoPLEX, for the treatment of intra-tumoral cancer.
PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 14, 24 | -1.25 Decreased by -861.54% | -1.30 Increased by +3.85% |
| May 8, 24 | -1.37 Decreased by -389.29% | -1.41 Increased by +2.84% |
| Feb 14, 24 | -3.97 Decreased by -1.14 K% | -3.58 Decreased by -10.89% |
| Nov 8, 23 | -3.40 Decreased by -608.33% | -4.16 Increased by +18.27% |
| Aug 9, 23 | -0.13 Increased by +78.69% | -0.31 Increased by +58.06% |
| May 10, 23 | -0.28 Increased by +55.56% | -0.26 Decreased by -7.69% |
| Feb 8, 23 | -0.32 Increased by +54.93% | -0.41 Increased by +21.95% |
| Nov 9, 22 | -0.48 Increased by +9.43% | -0.54 Increased by +11.11% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 24 | 0.00 Decreased by N/A% | -6.29 M Decreased by -7.83% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -6.45 M Decreased by -6.26% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | -6.36 M Increased by +2.74% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | -5.60 M Increased by +39.55% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 23 | 0.00 Decreased by N/A% | -5.84 M Increased by +83.57% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -6.07 M Increased by +48.56% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -6.54 M Increased by +50.61% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -9.27 M Increased by +6.68% | Decreased by N/A% Decreased by N/A% |